Byrne, Mr James Patrick

Mr James ByrneBSc(Hons), MB.ChB, FRCS, MD, FRCS (Gen Surg)


General surgery


Upper gastro-intestinal surgery (oesophagigastric)

Training and education

  • University of St Andrews, 1982 to 1986
  • University of Manchester, 1986 to 1989
  • House officer and senior house officer, South Manchester, 1989 to 1994
  • Specialist registrar, North West Region, 1994 to 2002
  • Research fellow, University of Manchester, 1995 to 1997
  • Senior clinical fellow, Princess Alexandra Hospital, Brisbane, Australia, 2002


Mr Byrne strives to provide a high quality service together with the rest of the upper GI MDT for all patients with oesophageal and gastric cancer, focusing on all aspects of care as MDT lead. In the 2006 peer review of SUHT as a specialist centre for oesophagogastric cancer, compliance was achieved with 83% of level 1* and 77% of level 1 and 2 standards. The team was commended as well run and cohesive and for participation in research trials at the last peer review.

Mr Byrne introduced thoracolaparoscopic surgery for oesophagela and gastric cancer to Southampton and has developed this service further with his colleague Jamie Kelly. The unit now has a high level of expertise in minimally invasive oeosphageal resection in the UK. This is reflected in the prestigious appointment to the unit of a surgical fellow by the Royal College of Surgeons.

Laparoscopic adrenalectomy in Southampton has been developed in collaboration with Dr Derek Sandeman, consultant endocrinologist, since 2006. The average length of stay for these procedures is now 1 to 2 days. Mr Byrne performed the first laparoscopic bilateral adrenalectomy in a child at Southampton in 2009 with Lara Kitteringham, such patients formerly being referred to Great Ormond Street Hospital.

Key achievements

  • Creation of multidisciplinary bariatric surgical research group in Southampton with membership of public health, health economics, diabetes and endocrinology, primary care and user involvement.
  • Award of NHS RFPB grant for £220k (2009) to evaluate role of bariatric surgery among diabetics with a BMI of 30 to 40.
  • Since January 2005 the oesophagogastric team has performed over 250 resections for patients with oesophageal or gastric cancer with seven in-hospital deaths, giving a combined mortality rate of just under 3%. This compares very favourably with 2009 UK National Audit in-hospital mortality rates of 4 to 6% for oesophagectomy and 5 to 10% for gastrectomy.

Awards and prizes

British Journal of Surgery Prize, Association of Upper Gastrointestinal Surgeons, 2002.


  • Impact of PET-CT on management of oesophageal cancer - population based UK cohort study. Noble F, Bailey D; SWCIS Upper Gastrointestinal Tumour Panel, Tung K, Byrne JP. Clin Radiol. 2009 Jul;64(7):699-705. 
  • Beneficial cardiovascular effects of bariatric surgical and dietary weight loss in obesity. Rider OJ, Francis JM, Ali MK, Petersen SE, Robinson M, Robson MD, Byrne JP, Clarke K, Neubauer S. J Am Coll Cardiol. 2009 Aug 18;54(8):718-26
  • A two-consultant approach is a safe and efficient strategy to adopt during the learning curve for Laparoscopic Roux-en-Y gastric bypass : our results in the first 100 procedures. Abu Hilal M, VanDen Bossche M, Bailey IS, Harb A, Sansome AJ, Byrne JP. Obesity Surgery 2007;17(6):742-


You can contact Mr Byrne via his secretary on 023 8120 3091.